|
⚲
|
| Farallon Biosciences Inc | |
|---|---|
| Firm | |
| Fund # | |
| CIK # | 0001463270 |
| Sale | 2009-05-19 ($8.0 M Offered, $4.0 M Sold) |
| Fund | |
| Phone | 8585506088 |
| Address | 2825 Crystal Ridge Road Encinitas, 92024 |
| Source | [EDGAR] |
| Fund AUM and Sold ($M) |
|---|
| Fund Details | |
|---|---|
| Director | |
| Custodian | |
| Auditor | |
| Marketer | |
| Broker | |
| Jurisdiction |
| Directors | 2011 - 2025 |
|---|---|
| Richard Heyman | |
| Peter Svennilson | |
| Carl Gordon |
| Comparable Firms | State | AUM ($B) |
|---|---|---|
|
SE Fund I, a series of Chemistry Funds, LP
✚
|
0.0 | |
|
SE Fund II, a series of Riverside Ventures, LP
✚
|
0.0 | |
|
Sefzik Peter L
✚
|
0.0 | |
|
Paulson Larry
✚
|
0.0 | |
|
Pau Nathan
✚
|
0.0 | |
|
Paup Mark A
✚
|
0.0 | |
|
Pavelski John Stuart
✚
|
0.0 | |
|
PAVmed Inc.
✚
|
0.0 | |
|
Pawlak Chad Lee Sr.
✚
|
0.0 | |
|
Sefchick Adam Brett
✚
|
0.0 |